BioNTech
BNTX
BNTX
225 hedge funds and large institutions have $3.25B invested in BioNTech in 2021 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 71 increasing their positions, 47 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.4% more ownership
Funds ownership: 9.13% → 12.53% (+3.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
23% less call options, than puts
Call options by funds: $301M | Put options by funds: $391M
Holders
225
Holding in Top 10
1
Calls
$301M
Puts
$391M
Top Buyers
| 1 | +$716M | |
| 2 | +$53.1M | |
| 3 | +$46M | |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$39M |
| 5 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
+$37M |
Top Sellers
| 1 | -$122M | |
| 2 | -$47.3M | |
| 3 | -$20.9M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20.7M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$19.9M |